D. Warne

Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins.

E. Loumaye, A. Lass, A. Vassiliev, 2002, Fertility and sterility.

Magmaris resorbable magnesium scaffold versus conventional drug-eluting stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison.

T. Pilgrim, P. Xaplanteris, J. Iglesias, 2022, Cardiovascular revascularization medicine : including molecular interventions.

Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.

V. Alam, D. Tredway, R. Homburg, 2010, Reproductive biomedicine online.

Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism.

P. Bouloux, E. Loumaye, D. Warne, 2002, Fertility and sterility.

A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.

C. Howles, H. Okada, G. Decosterd, 2009, Fertility and sterility.

A comparison of 3-day and daily follicle-stimulating hormone injections on stimulation days 1-6 in women undergoing controlled ovarian hyperstimulation.

M. Scholtes, D. Warne, H. Verhoeven, 2004, Fertility and sterility.

Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa.

F. Broekmans, G. Trew, A. Borini, 2015, Reproductive biomedicine online.

Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysis.

A. Eshkol, V. Alam, D. Tredway, 2011, The Journal of reproductive medicine.

Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study

F. Barkhof, D. MacManus, M. Sormani, 2021, Multiple sclerosis.